KDA Group

KDA Group EV/EBIT

The EV/EBIT (Enterprise Value to EBIT) of KDA Group (KDA.V) as of Nov 3, 2026 is -4.70. In the previous year, EV/EBIT (Enterprise Value to EBIT) was -9.07 — a change of -48.21% (higher).

EV/EBIT

-4.70

YoY

-48.21%

Last updated:

EV/EBIT (Enterprise Value to EBIT) of KDA Group is 2025 -4.70 . EV/EBIT (Enterprise Value to EBIT) of KDA Group was 2024 -9.07 . It decreases by -48.21% higher compared to the previous year.

The KDA Group EV/EBIT history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EV/EBIT
Date
EV/EBIT
Jan 1, 2018
45.79 CAD
Jan 1, 2019
-95.13 CAD
Jan 1, 2020
-520.03 CAD
Jan 1, 2021
25.61 CAD
Jan 1, 2022
28.69 CAD
Jan 1, 2023
-12.69 CAD
Jan 1, 2024
-9.07 CAD
Jan 1, 2025
-4.70 CAD
The KDA Group EV/EBIT history
YEAREV/EBITYoY
-4.70-48.21%
-9.07-28.56%
-12.69-144.24%
28.69+12.03%
25.61-104.93%
-520.03+446.65%
-95.13-307.76%
45.79-245.14%
-31.55+44.12%
-21.89-67.17%
-66.69-259.27%
41.87-1,055.93%
-4.38+224.44%
-1.35-53.77%
-2.92+186.27%
-1.02-89.55%
-9.76—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

KDA Group Valuation

Details

Historical Valuation Multiples

ⓘ

Price-to-Earnings Ratio (P/E)

The P/E ratio divides KDA Group's share price by its earnings per share. It tells you how many years of current earnings you are "paying for" when you buy the stock. A P/E of 20 means you pay $20 for every $1 of annual earnings. The S&P 500 historically trades at an average P/E of roughly 15–17. A P/E significantly above that may signal high growth expectations; one below may indicate undervaluation — or declining business quality.

Price-to-Sales Ratio (P/S)

The P/S ratio divides market capitalization by total revenue. Unlike the P/E ratio, it works even for companies that are not yet profitable, making it essential for evaluating high-growth firms. A P/S below 1.0 may indicate undervaluation, while ratios above 10 are typically reserved for fast-growing tech or SaaS companies with high expected future margins.

Price-to-EBIT Ratio

This ratio relates KDA Group's market price to its operating earnings, excluding the effects of debt structure and tax jurisdiction. It is particularly useful for comparing companies across different countries or with different levels of leverage, because it focuses purely on operational profitability. Lower values suggest cheaper operational earnings.

How to Use This Chart

This chart plots KDA Group's valuation multiples over time. Compare the current P/E, P/S, and P/EBIT to their own historical averages — if the current ratio is well below the multi-year average, the stock may be relatively cheap compared to its own track record. Combine this with industry comparisons: a P/E that looks high in absolute terms may be justified if KDA Group grows earnings faster than its peers.

KDA Group Stock analysis

What does KDA Group do? KDA Group, Inc. generates revenue through its Pharmacy Services, Pharmaceutical Solutions, and Pharmaceutical Technology segments. The Pharmacy Services segment provides training, consulting, and replacement services for healthcare professionals. The Pharmaceutical Solutions segment develops and integrates technological platforms for healthcare professionals. The Pharmaceutical Technology segment offers KRX, KRX DENTAL, and ADRX platforms, while ZRx Digital Prescriber is an electronic prescriber software for authorized healthcare providers. Subsidiaries like Alliance Pharma Operations Inc. and Elitis Pharma Inc. support these services. Clients include healthcare professionals who require training, consulting, and technological solutions. The Pharmacy Services segment targets professional resource needs in healthcare, while Pharmaceutical Solutions and Technology segments serve healthcare professionals with integrated platforms and digital tools. Subsidiaries such as Logistik Pharma Inc. and Groupe Technologique KDA Inc. contribute to the company's service delivery. Pharmaceutical Technology platforms like KRX, KRX DENTAL, and ADRX are sold to healthcare professionals seeking digital solutions. ZRx Digital Prescriber is utilized by authorized prescribers for medication and treatment management. The company's subsidiaries operate within the segments to deliver specialized services, ensuring comprehensive solutions for healthcare providers. KDA Group is one of the most popular companies on Eulerpool.

Frequently Asked Questions about KDA Group stock

EV/EBIT (Enterprise Value to EBIT) of KDA Group is -4.70 in 2025.

EV/EBIT (Enterprise Value to EBIT) of KDA Group changed from -9.07 to -4.70, representing a -48.21% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EV/EBIT (Enterprise Value to EBIT) KDA Group since 2006 – with annual values, charts, and detailed analysis.

The EV/EBIT ratio measures a company's enterprise value relative to its operating earnings. It accounts for debt, making it useful for comparing companies with different capital structures.

EV/EBIT = Enterprise Value / Earnings Before Interest and Taxes

To evaluate EV/EBIT (Enterprise Value to EBIT)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/EBIT (Enterprise Value to EBIT).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/EBIT (Enterprise Value to EBIT)'s KDA Group with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — KDA Group

All Key Metrics — KDA Group